Literature DB >> 20228416

Involvement of oxytocin in the nucleus tractus solitarii on central cardiovascular control: interactions with glutamate.

C Vela1, Z Diaz-Cabiale, C Parrado, M Narvaez, R Covenas, J A Narvaez.   

Abstract

Oxytocin (OT) is a peptide involved in several physiological functions in the central nervous system including central cardiovascular regulation. To clarify the role of endogenous OT in cardiovascular control, one group of anesthetized rats received unilateral microinjections of the OT receptor antagonist [d(CH(2))(5),Tyr(Me)(2),Orn(8)]-vasotocin (OTA) in the nucleus tractus solitarii (NTS) and a second group was injected with specific OT antiserum (Anti-OT). Moreover, the modulation of the cardiovascular effect of L-glutamate (GLU) by OT was also evaluated by cardiovascular analysis using effective and threshold doses of GLU. Mean arterial pressure (MAP) and heart rate (HR) were measured from a femoral catheter. OTA significantly (p<0.01) decreased the vasopressor and tachycardiac long-lasting response elicited by an effective dose of OT. Microinjections of Anti-OT antibody did not modify the values of MAP and HR compared with the control group. With regard to the OT/GLU coinjections, a subthreshold dose of OT significantly (p<0.001) counteracted the vasodepressor and bradycardiac responses induced by GLU. The coinjection of subthreshold doses of OT and GLU did not produce a change in MAP or in HR. These findings seem to exclude an endogenous tonic action of OT on central regulation of MAP and HR, although they confirm the significant role of OT on central cardiovascular control within the NTS. In fact, the modulation of GLU responses by OT supports the importance of OT on the central cardiovascular adjustments likely acting on the baroreceptor reflex sensitivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228416

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  6 in total

1.  Glutamate transporter type 3 knockout leads to decreased heart rate possibly via parasympathetic mechanism.

Authors:  Jiao Deng; Jiejie Li; Liaoliao Li; Chenzhuo Feng; Lize Xiong; Zhiyi Zuo
Journal:  Transgenic Res       Date:  2013-01-30       Impact factor: 2.788

2.  Neuropeptides in the posterodorsal medial amygdala modulate central cardiovascular reflex responses in awake male rats.

Authors:  E Quagliotto; K R Casali; P Dal Lago; A A Rasia-Filho
Journal:  Braz J Med Biol Res       Date:  2014-11-21       Impact factor: 2.590

3.  Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats.

Authors:  Maja Lozić; Michael Greenwood; Olivera Šarenac; Andrew Martin; Charles Hindmarch; Tatjana Tasić; Julian Paton; David Murphy; Nina Japundžić-Žigon
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation.

Authors:  Jack H Jhamandas; Valeri Goncharuk
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-07       Impact factor: 5.555

5.  Distinct BOLD Activation Profiles Following Central and Peripheral Oxytocin Administration in Awake Rats.

Authors:  Craig F Ferris; Jason R Yee; William M Kenkel; Kelly Marie Dumais; Kelsey Moore; Alexa H Veenema; Praveen Kulkarni; Allison M Perkybile; C Sue Carter
Journal:  Front Behav Neurosci       Date:  2015-09-17       Impact factor: 3.558

Review 6.  Non-Opioid Peptides Targeting Opioid Effects.

Authors:  Katarzyna Kaczyńska; Piotr Wojciechowski
Journal:  Int J Mol Sci       Date:  2021-12-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.